University of Texas's MD Anderson Cancer Center: Newly Developed Radio-Labeled Molecule Enables Real-Time Imaging of Innate Immune Activity
February 22, 2022
February 22, 2022
HOUSTON, Texas, Feb. 22 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Feb. 21, 2022:
* * *
Study suggests molecule offers improved specificity to monitor inflammation across many potential clinical applications
* * *
Researchers at The University of Texas MD Anderson Cancer Center have developed a new radio-labeled molecule capable of selectively reacting with certain high-energy radic . . .
* * *
Study suggests molecule offers improved specificity to monitor inflammation across many potential clinical applications
* * *
Researchers at The University of Texas MD Anderson Cancer Center have developed a new radio-labeled molecule capable of selectively reacting with certain high-energy radic . . .